Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable sustained-release celecoxib hydrogel versus Hyalgan for knee osteoarthritis
IRCT20221101056363N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in knee osteoarthritis (OA) comparing Celecoxib hydrogel with Hyalgan comparator (2 arms). Primary endpoints: Range of motion, Sit-to-stand test and 8 more. Started Jan 2023; status: completed.
02
Drugs
celecoxibsodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20221101056363N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221101056363N1.